This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignees: Jcr Pharmaceuticals Co., Ltd., Waseda University. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014
Title: Hideo Kanazawa: Innovator in Drug Delivery Systems
Introduction
Hideo Kanazawa is a renowned inventor based in Tokyo, Japan, known for his significant contributions to drug delivery technology. With a focus on improving pharmacokinetics, he has developed innovative solutions to enhance the efficacy of drug carriers.
Latest Patents
Hideo Kanazawa holds one notable patent for a drug carrier designed to control in vivo pharmacokinetics. This innovative drug carrier consists of a molecular assembly that incorporates a drug within its structure. The invention takes advantage of the amphiphilic molecules present in the assembly, which can be released in response to external environmental changes. By shifting the hydrophilic-hydrophobic balance of these molecules toward hydrophilicity, the drug carrier facilitates targeted drug delivery, enhancing its therapeutic effectiveness.
Career Highlights
Throughout his career, Hideo Kanazawa has worked with prestigious organizations such as JCR Pharmaceuticals Co., Ltd. and Waseda University. His experience in both academia and industry has enriched his understanding of drug delivery systems, allowing him to bridge the gap between research and practical applications.
Collaborations
In his pursuit of innovative drug delivery systems, Kanazawa has collaborated with esteemed colleagues, including Shinji Takeoka and Yosuke Okamura. Together, they have worked on advancing technologies that hold promise for the pharmaceutical industry.
Conclusion
Hideo Kanazawa exemplifies the spirit of innovation in the field of drug delivery systems. His patent serves as a testament to his ingenuity and commitment to enhancing therapeutic outcomes through advanced molecular assemblies. As he continues to contribute to the field, his work inspires future generations of inventors and researchers in the pursuit of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile